NeuroBo Pharmaceuticals, Inc. (NRBO) Financials

NRBO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 26.4 million 4.9 million
2023-06-30 29.2 million 4.0 million
2023-03-31 31.5 million 11.0 million
2022-12-31 33.5 million 11.8 million

NRBO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.9 million 172000
2023-06-30 -2.0 million 24000
2023-03-31 -2.6 million -74000
2022-12-31 -1.8 million 218000

NRBO Net Income

No data available :(

NRBO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 25.8 million - 218000
2023-06-30 28.7 million - -
2023-03-31 30.8 million - -
2022-12-31 33.4 million - -

NRBO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 40.6 million
2023-06-30 40.5 million
2023-03-31 27.2 million
2022-12-31 25.4 million

NRBO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 37000 2.3 million 1.6 million -
2023-06-30 - 2.4 million 1.4 million -
2023-03-31 4000 637000 1.9 million -
2022-12-31 - 305000 1.9 million -

NRBO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 1000
2023-06-30 - -
2023-03-31 - 1000
2022-12-31 - 1000

NRBO

Price: $3.84

52 week price:
2.89
6.75

Earnings Per Share: -2.46 USD

P/E Ratio: -0.12

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 985600

Market Capitalization: 18.5 million

Links: